113 results
8-K
EX-99.1
ALNY
Alnylam Pharmaceuticals Inc
7 Apr 11
Other Events
12:00am
of Tekmira Pharmaceuticals Corporation.
By engaging in a public campaign to impugn Alnylam’s reputation, Tekmira has once again demonstrated its … Alnylam’s reputation with its collaborators and investors.
21. In addition, and as set forth more fully below, Tekmira has also violated the parties
S-1
EX-10.23
ALNY
Alnylam Pharmaceuticals Inc
27 Feb 04
IPO registration
12:00am
business to which this Agreement pertains (as long
as the reputation of such entity would not negatively impact MAYO's reputation
as a health care
8-K
EX-99.1
ALNY
Alnylam Pharmaceuticals Inc
14 Jan 13
Other Events
12:00am
to be disruptive to our operations. For example, cost savings measures may distract management from our core business, harm our reputation, yield unanticipated … reputation.
As a manufacturer of pharmaceuticals, we are subject to federal, state, and foreign healthcare laws and regulations pertaining to fraud
8-K
EX-99.1
ALNY
Alnylam Pharmaceuticals Inc
29 Jun 11
Entry into a Material Definitive Agreement
12:00am
’ agreements and filed this action without any advance warning; (ii) engaged in a public campaign to impugn Alnylam’s reputation through press releases … the original complaint. These actions have irreparably harmed Alnylam’s reputation with its collaborators and investors.
30. Further, in violation